586 results on '"Ellinger, J."'
Search Results
102. Expressionsanalyse der Untereinheiten des mitochondrialen Komplex III - UQCRC1 als prognostischer Marker für das klarzellige Nierenzellkarzinom
103. Die Mediatorkomplex Untereinheit MED15: Ein Tumorpromotor im Nierenzellkarzinom
104. Analyse der Genregulation von Mitgliedern der mitochondrialen Elektronentransportkette bei Patienten mit einem Nierenzellkarzinom
105. Identification of aberrant expression of tRNA halves in renal cell carcinoma
106. The Mediator complex subunit MED8 is implicated in the progression of renal cell carcinoma
107. Identification of novel biomarkers in clear cell renal cell carcinoma
108. H 16 - Tumoren der ableitenden Harnwege
109. Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma
110. Prädiktion des krebsspezifischen Überlebens nach radikaler Zystektomie beim Harnblasenkarzinom unter Anwendung artifizieller neuronaler Netzwerke
111. Transplantat-Nephrektomie - Bonner Erfahrungen von 1999-2012
112. Die Bedeutung der Mediator-Komplex Untereinheit MED12 während der Progression des muskelinvasiven Blasenkarzinoms
113. Erstvorstellung der onkologischen TRIFECTA- und PENTAFECTA-Kriterien zur Verbesserung der Prognosestratifizierung nach radikaler Zystektomie
114. Identification of novel biomarkers for patients with renal cell carcinoma
115. The Mediator complex subunit MED8 is implicated in the progression of renal cell carcinoma
116. Identification of novel biomarkers in clear cell renal cell carcinoma
117. Identification of aberrant expression of tRNA halves in renal cell carcinoma
118. 120 The Mediator complex subunit MED8 is implicated in the progression of papillary renal cell carcinoma
119. Multivariate Schematic Design Tooling
120. Transplantat-Nephrektomie - Bonner Erfahrungen von 1999-2012
121. Prädiktion des krebsspezifischen Überlebens nach radikaler Zystektomie beim Harnblasenkarzinom unter Anwendung artifizieller neuronaler Netzwerke
122. Die Bedeutung der Mediator-Komplex Untereinheit MED12 während der Progression des muskelinvasiven Blasenkarzinoms
123. Erstvorstellung der onkologischen TRIFECTA- und PENTAFECTA-Kriterien zur Verbesserung der Prognosestratifizierung nach radikaler Zystektomie
124. Identification of novel long non-coding RNAs in clear cell renal cell carcinoma
125. 306 - Vascular expression of prostate-specific membrane antigen in renal tumors: Diagnostic and prognostic role
126. Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer
127. 863 Identification and functional analysis of novel long non-coding RNAs in clear cell renal cell carcinoma
128. 538 Prediction of cancer-specific survival in patients with radical cystectomy for bladder cancer using artificial neural networks
129. 756 The Mediator complex subunit MED12 is implicated in the progression of urothelial cell carcinoma of the urinary bladder
130. H3+ as a trap for noble gases-3: Multiple trapping of neon, argon, and krypton in XnH3+ (n=1–3)
131. 985 - Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma
132. Nachweis von zellfreier lncRNA im Serum von Tumorpatienten
133. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation
134. 286 Clinical and pathological nodal staging score for urothelial carcinoma of the bladder are valid decision tools for risk assessment and clinical decision-making: An external validation
135. 775 Female gender is associated with worse cancer-specific survival after radical cystectomy for urothelial bladder carcinoma: Multicenter analysis of 2,483 patients
136. 872 External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for muscle invasive urothelial carcinoma of the bladder
137. 244 MULTICENTRIC VALIDATION OF NOMOGRAMS TO PREDICT LOCALLY ADVANCED UROTHELIAL CANCER OF THE BLADDER AND SURVIVAL RATES FOLLOWING RADICAL CYSTECTOMY
138. 866 ASSOCIATION BETWEEN THE EXTENT OF PELVIC LYMPHADENECTOMY AND CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH LYMPH NODE NEGATIVE UROTHELIAL CARCINOMA OF THE BLADDER UNDERGOING RADICAL CYSTECTOMY
139. 243 PREDICTION OF LOCALLY ADVANCED BLADDER CANCER BEFORE CYSTECTOMY AND OUTCOME ASSESSMENT OF PATIENTS WITH BLADDER CANCER AFTER CYSTECTOMY USING ARTIFICIAL NEURAL NETWORKS
140. Autorenverzeichnis
141. 568 GLOBAL HISTONE H3 LYSINE 27 (H3K27) METHYLATION LEVELS AND THERE PROGNOSTIC RELEVANCE IN RENAL CELL CARCINOMA
142. 897 GLOBAL HISTONE MODIFICATIONS PREDICT BIOCHEMICAL RECURRENCE IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER
143. Tomaten und Lykopin in Prävention und Therapie – Gibt es eine Evidenz bei Prostataerkrankungen?
144. Prostatakarzinomforschung
145. CELL-FREE DNA IN SERUM: A NOVEL DIAGNOSTIC MARKER FOR PATIENTS WITH TESTICULAR CANCER
146. HYPERMETHYLATION OF CELL-FREE SERUM DNA INDICATES WORSE OUTCOME IN PATIENTS WITH BLADDER CANCER
147. CELL-FREE DNA IN SERUM OF PATIENTS WITH BLADDER CANCER: DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS
148. Soy isoflavone genistein in prevention and treatment of prostate cancer
149. Epigenetik des Prostatakarzinoms
150. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.